FDA Inspection 1025638 — Purdue Pharma
The FDA completed an inspection of Purdue Pharma on Aug 4, 2017 in Pickering. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 4, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Pickering (Canada)